Related Experiment Video
Updated: Aug 12, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
Update on cardiogenic shock: from detection to team management
Yevgeniy Khariton1, Ossama Abou Hassan, Jaime A Hernandez-Montfort
1Baylor Scott and White Health - Temple, Texas, USA.
Current Opinion in Cardiology
|January 31, 2023
Summary
This review summarizes current strategies for diagnosing and managing cardiogenic shock (CS), differentiating between acute myocardial infarction (AMI)-CS and heart failure (HF)-CS. It emphasizes algorithmic approaches and team-based care for improved patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Contemporary cardiogenic shock (CS) management requires updated profiling and diagnostic strategies.
- Understanding clinical differences between acute myocardial infarction (AMI)-CS and heart failure (HF)-CS is crucial for tailored treatment.
Approach:
- This review synthesizes scientific consensus, clinical trial data, and registry findings on CS management.
- It examines biomarker and hemodynamic monitoring, including invasive and noninvasive methods.
- The review discusses transitions to native heart recovery and heart replacement therapies.
Key Points:
- Pulmonary artery catheterization is vital for both AMI-CS and HF-CS.
- Algorithmic approaches integrating clinical, hemodynamic, and imaging data are advocated.
- Interdisciplinary care pathways and protocol-driven care are essential.
Conclusions:
- Routine application of algorithmic approaches and interdisciplinary care pathways can optimize hemodynamic support and organ perfusion in CS.
- Tailored management strategies, informed by real-world data, are key for improving CS patient trajectories.
- Team-based initiatives are trending for effective CS interventions.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
61
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
61
01:30Heart Failure V: Medical Management
19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
01:28Acute Coronary Syndrome IV: Interprofessional Care
20
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
01:29Cardiomyopathy V: Interprofessional Care
22
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
01:24Blood Pressure Imbalances and Circulatory Shock
889
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
889
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
25
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
25